Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical drug development: an analysis of phase II trials, 1970-1985.
Marsoni S, Hoth D, Simon R, Leyland-Jones B, De Rosa M, Wittes RE. Marsoni S, et al. Among authors: hoth d. Cancer Treat Rep. 1987 Jan;71(1):71-80. Cancer Treat Rep. 1987. PMID: 3791270
2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
O'Dwyer PJ, Wagner B, Leyland-Jones B, Wittes RE, Cheson BD, Hoth DF. O'Dwyer PJ, et al. Among authors: hoth df. Ann Intern Med. 1988 May;108(5):733-43. doi: 10.7326/0003-4819-108-5-733. Ann Intern Med. 1988. PMID: 3282467 Review.
Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.
Grem JL, Hoth DF, Hamilton JM, King SA, Leyland-Jones B. Grem JL, et al. Among authors: hoth df. Cancer Treat Rep. 1987 Dec;71(12):1249-64. Cancer Treat Rep. 1987. PMID: 3319136 Review. No abstract available.
Investigational trials of anticancer drugs: establishing safeguards for experimentation.
Chabner BA, Wittes R, Hoth D, Hubbard S. Chabner BA, et al. Among authors: hoth d. Public Health Rep. 1984 Jul-Aug;99(4):355-60. Public Health Rep. 1984. PMID: 6431482 Free PMC article.
Phase-II trial of tamoxifen in advanced breat cancer.
Wiggans RG, Woolley PV, Smythe T, Hoth D, Macdonald JS, Green L, Schein PS. Wiggans RG, et al. Among authors: hoth d. Cancer Chemother Pharmacol. 1979;3(1):45-8. doi: 10.1007/BF00254419. Cancer Chemother Pharmacol. 1979. PMID: 535127
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
Morgan LR Jr, Schein PS, Woolley PV, Hoth D, Macdonald J, Lippman M, Posey LE, Beazley RW. Morgan LR Jr, et al. Among authors: hoth d. Cancer Treat Rep. 1976 Oct;60(10):1437-43. Cancer Treat Rep. 1976. PMID: 191185
Phase II study of chlorozotocin in leukemia and other hematologic malignancies.
Pavlovsky S, Woolley PV, Garay G, Scaglione C, Hoth D, Schein PS. Pavlovsky S, et al. Among authors: hoth d. Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1109-11. Cancer Treat Rep. 1981. PMID: 6457686 No abstract available.
Phase I clinical trial of spirogermanium.
Schein PS, Slavik M, Smythe T, Hoth D, Smith F, Macdonald JS, Woolley PV. Schein PS, et al. Among authors: hoth d. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1051-6. Cancer Treat Rep. 1980. PMID: 7459890
Phase II study of chlorozotocin in non-small cell carcinoma of the lung.
Cornell CJ Jr, Hoth D, Pajak TF. Cornell CJ Jr, et al. Among authors: hoth d. Cancer Treat Rep. 1981 Jul-Aug;65(7-8):734-5. Cancer Treat Rep. 1981. PMID: 6454488 No abstract available.
Results of NCI-sponsored phase I trials with carboplatin.
Foster BJ, Clagett-Carr K, Leyland-Jones B, Hoth D. Foster BJ, et al. Among authors: hoth d. Cancer Treat Rev. 1985 Sep;12 Suppl A:43-9. doi: 10.1016/0305-7372(85)90017-9. Cancer Treat Rev. 1985. PMID: 3910221
74 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback